Showing results (131-140 of 185) with videos related to
Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2016
Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic TracersSvetlana N Rylova, Beatrice Waser, Luigi Del Pozzo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targetingMihaela Ginj, Hanwen Zhang, Klaus-Peter Eisenwiener, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|December 21, 2005
Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solutionMargarida Gairí, Pilar Saiz, Sergio Madurga, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2011
First clinical evidence that imaging with somatostatin receptor antagonists is feasibleDamian Wild, Melpomeni Fani, Martin Behe, et al.EJNMMI Research|June 12, 2012
[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical studyAikaterini Tatsi, Theodosia Maina, Renzo Cescato, et al.Bioconjugate Chemistry|May 15, 2015
Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptorPetra Kolenc Peitl, MariaLuisa Tamma, Marko Kroselj, et al.Journal of Medicinal Chemistry|April 9, 2009
Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analoguesJudit Erchegyi, Renzo Cescato, Christy Rani R Grace, et al.Journal of Medicinal Chemistry|December 12, 2003
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8Judit Erchegyi, Botond Penke, Lajos Simon, et al.Journal of Medicinal Chemistry|July 10, 2014
[111In-DOTA]LTT-SS28, a first pansomatostatin radioligand for in vivo targeting of somatostatin receptor-positive tumorsTheodosia Maina, Renzo Cescato, Beatrice Waser, et al.EJNMMI Research|February 18, 2014
Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumorsAndreas Wicki, Damian Wild, Vincent Prêtre, et al.Pageof 19